Automatic Hydraulic Laboratory Press Featured at Pittcon 2018
Pharmaceutical Technology's In the Lab eNewsletter
Carver will feature its Auto Series Plus automatic hydraulic laboratory press at Pittcon 2018.
Carver, a manufacturer and supplier of standard and custom hydraulic presses for laboratory applications, has developed its Auto Series Plus automatic hydraulic laboratory press, according to a press statement released on Jan. 23, 2018.
The device features a large 7-in. color operator interface, enhanced platen temperature control and auto-tuning, ramp heating capability, real-time trending of force and temperature, and seven-day timer for auto heat-up. Other features include storage of up to 250 recipes, recipe preview, and optional data logging for cycle parameters.
Press models are available with 15–48 tons of clamping force and 6 x 6-in. to 19 x 19-in. platens. These benchtop presses are used in quality control and research and development for test sample preparations, destructive testing, molding, laminating and fluid extraction, according to the company.
The device will be featured at Pittcon 2018 in Booth No. 3453 from Feb. 26–Mar. 1 at the Orange County Convention Center in Orlando, FL.
Source: Carver
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
